"FDA approves AbbVie’s Emblaveo for intra-abdominal infections" was originally created and published by Pharmaceutical ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...
This column describes a ventral abdominal approach for castration in ... collar on the rat and begin antibiotics for secondary infection. Complications associated with castration include hematoma ...